Artificial Intelligence and the Future of Addiction Medicine

Friday, April 24, 2026

10:45 AM - 12:00 PM PT

Location: Seaport Ballroom, Level 2

Presenter(s)

Sara J. Polley, MD, FAPA, FASAM

Child, Adolescent, Adult, Addiction Psychiatrist
Vantage Mental Health
Minneapolis, Minnesota

Slides
Emily Brunner, MD

Supervising physician consultant
Hazelden Betty Ford Foundation
Lake Elmo, Minnesota
Michael Eiden, PhD, LCSW, LCADC, CSAT, CCS

Therapist
Eiden Integrative Counseling
Milwaukie, Oregon
Daniel Kaufmann, PhD, LPC, LMHC

Director of Gaming Services & Program Development | Associate Professor
Kindbridge Behavioral Health | Grand Canyon University
Orlando, Florida

Explore how artificial intelligence is transforming addiction medicine—from predicting risk and personalizing treatment to supporting recovery—while uncovering its risks for mental health and addictive use. Learn practical strategies to integrate AI safely, ethically, and equitably into clinical care. This session offers clinicians actionable insights to harness technology without compromising human connection.

Learning Objectives:

Learners will be able to:

Describe current and emerging applications of artificial intelligence across prevention, diagnosis, treatment, and recovery in addiction care.
Evaluate the evidence base, benefits, and limitations of artificial intelligence tools used in clinical and telehealth settings, including implications for equity and patient engagement.
Identify risks of addictive use of artificial intelligence, its mental health impacts, and strategies for safe and ethical integration of AI tools into clinical addiction care.

Disclosure(s):

Sara J. Polley, MD, FAPA, FASAM: No financial relationships to disclose

Emily Brunner, MD: No financial relationships to disclose

Michael Eiden, PhD, LCSW, LCADC, CSAT, CCS: No financial relationships to disclose

Daniel Kaufmann, PhD, LPC, LMHC: No financial relationships to disclose